United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aug 17, 2026-- United Therapeutics Corporation (Nasdaq: UTHR ) announced full enrollment of its TETON-PPF study evaluating the use of Tyvaso ® (treprostinil) inhalation solution ( …